Circle8 Group, Inc. (NASDAQ: CIRC) Stock Competitors & Peer Comparison

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, RPRX has a market cap of 25.7B. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while RPRX trades at $57.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas RPRX's P/E ratio is 11.04. In terms of profitability, CIRC's ROE is +0.00%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, CIRC is more volatile compared to RPRX. This indicates higher risk in terms of short-term price fluctuations for CIRC.Check RPRX's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, CORT has a market cap of 12.3B. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while CORT trades at $114.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas CORT's P/E ratio is 326.37. In terms of profitability, CIRC's ROE is +0.00%, compared to CORT's ROE of +0.08%. Regarding short-term risk, CIRC is more volatile compared to CORT. This indicates higher risk in terms of short-term price fluctuations for CIRC.Check CORT's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while WBA trades at $11.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas WBA's P/E ratio is -1.64. In terms of profitability, CIRC's ROE is +0.00%, compared to WBA's ROE of -0.42%. Regarding short-term risk, CIRC is more volatile compared to WBA. This indicates higher risk in terms of short-term price fluctuations for CIRC.Check WBA's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, LQDA has a market cap of 8.1B. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while LQDA trades at $91.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas LQDA's P/E ratio is 650.21. In terms of profitability, CIRC's ROE is +0.00%, compared to LQDA's ROE of +0.47%. Regarding short-term risk, CIRC is more volatile compared to LQDA. This indicates higher risk in terms of short-term price fluctuations for CIRC.Check LQDA's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, KNSA has a market cap of 5.8B. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while KNSA trades at $76.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas KNSA's P/E ratio is 85.03. In terms of profitability, CIRC's ROE is +0.00%, compared to KNSA's ROE of +0.14%. Regarding short-term risk, CIRC is more volatile compared to KNSA. This indicates higher risk in terms of short-term price fluctuations for CIRC.Check KNSA's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, TRLV has a market cap of 1.5B. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while TRLV trades at $9.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas TRLV's P/E ratio is -21.50. In terms of profitability, CIRC's ROE is +0.00%, compared to TRLV's ROE of -0.44%. Regarding short-term risk, CIRC is more volatile compared to TRLV. This indicates higher risk in terms of short-term price fluctuations for CIRC.Check TRLV's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while HROWL trades at $25.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas HROWL's P/E ratio is N/A. In terms of profitability, CIRC's ROE is +0.00%, compared to HROWL's ROE of -0.34%. Regarding short-term risk, CIRC is more volatile compared to HROWL. This indicates higher risk in terms of short-term price fluctuations for CIRC.Check HROWL's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while HROWM trades at $26.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas HROWM's P/E ratio is N/A. In terms of profitability, CIRC's ROE is +0.00%, compared to HROWM's ROE of -0.34%. Regarding short-term risk, CIRC is more volatile compared to HROWM. This indicates higher risk in terms of short-term price fluctuations for CIRC.Check HROWM's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, LTGO has a market cap of 1.1B. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while LTGO trades at $18.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas LTGO's P/E ratio is N/A. In terms of profitability, CIRC's ROE is +0.00%, compared to LTGO's ROE of N/A. Regarding short-term risk, CIRC is less volatile compared to LTGO. This indicates lower risk in terms of short-term price fluctuations for CIRC.Check LTGO's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, CUVL has a market cap of 339.9M. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while CUVL trades at $6.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas CUVL's P/E ratio is N/A. In terms of profitability, CIRC's ROE is +0.00%, compared to CUVL's ROE of N/A. Regarding short-term risk, CIRC is more volatile compared to CUVL. This indicates higher risk in terms of short-term price fluctuations for CIRC.Check CUVL's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, LFMD has a market cap of 175.1M. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while LFMD trades at $3.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas LFMD's P/E ratio is -7.24. In terms of profitability, CIRC's ROE is +0.00%, compared to LFMD's ROE of -1.79%. Regarding short-term risk, CIRC is more volatile compared to LFMD. This indicates higher risk in terms of short-term price fluctuations for CIRC.Check LFMD's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, LFMDP has a market cap of 160.2M. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while LFMDP trades at $23.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas LFMDP's P/E ratio is -724.19. In terms of profitability, CIRC's ROE is +0.00%, compared to LFMDP's ROE of -1.79%. Regarding short-term risk, CIRC is more volatile compared to LFMDP. This indicates higher risk in terms of short-term price fluctuations for CIRC.Check LFMDP's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while RAD trades at $0.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas RAD's P/E ratio is -0.05. In terms of profitability, CIRC's ROE is +0.00%, compared to RAD's ROE of +2.76%. Regarding short-term risk, CIRC is less volatile compared to RAD. This indicates lower risk in terms of short-term price fluctuations for CIRC.Check RAD's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, GLTO has a market cap of 34.5M. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while GLTO trades at $21.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas GLTO's P/E ratio is -1.78. In terms of profitability, CIRC's ROE is +0.00%, compared to GLTO's ROE of -1.22%. Regarding short-term risk, CIRC is more volatile compared to GLTO. This indicates higher risk in terms of short-term price fluctuations for CIRC.Check GLTO's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, SCYX has a market cap of 32.4M. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while SCYX trades at $5.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas SCYX's P/E ratio is -1.51. In terms of profitability, CIRC's ROE is +0.00%, compared to SCYX's ROE of -0.57%. Regarding short-term risk, CIRC is more volatile compared to SCYX. This indicates higher risk in terms of short-term price fluctuations for CIRC.Check SCYX's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, NSRX has a market cap of 29.4M. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while NSRX trades at $3.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas NSRX's P/E ratio is -4.74. In terms of profitability, CIRC's ROE is +0.00%, compared to NSRX's ROE of +0.00%. Regarding short-term risk, CIRC is more volatile compared to NSRX. This indicates higher risk in terms of short-term price fluctuations for CIRC.Check NSRX's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, SDEV has a market cap of 27.6M. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while SDEV trades at $1.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas SDEV's P/E ratio is -0.18. In terms of profitability, CIRC's ROE is +0.00%, compared to SDEV's ROE of +7.90%. Regarding short-term risk, CIRC is more volatile compared to SDEV. This indicates higher risk in terms of short-term price fluctuations for CIRC.Check SDEV's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, CNSY has a market cap of 26.4M. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while CNSY trades at $3.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas CNSY's P/E ratio is -0.53. In terms of profitability, CIRC's ROE is +0.00%, compared to CNSY's ROE of N/A. Regarding short-term risk, CIRC is more volatile compared to CNSY. This indicates higher risk in terms of short-term price fluctuations for CIRC.Check CNSY's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, BFRI has a market cap of 15.5M. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while BFRI trades at $1.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas BFRI's P/E ratio is -1.13. In terms of profitability, CIRC's ROE is +0.00%, compared to BFRI's ROE of -4.77%. Regarding short-term risk, CIRC is more volatile compared to BFRI. This indicates higher risk in terms of short-term price fluctuations for CIRC.Check BFRI's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while CJJD trades at $1.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas CJJD's P/E ratio is -0.46. In terms of profitability, CIRC's ROE is +0.00%, compared to CJJD's ROE of -0.25%. Regarding short-term risk, CIRC is more volatile compared to CJJD. This indicates higher risk in terms of short-term price fluctuations for CIRC.Check CJJD's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while SSY trades at $1.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas SSY's P/E ratio is -2.86. In terms of profitability, CIRC's ROE is +0.00%, compared to SSY's ROE of -0.09%. Regarding short-term risk, CIRC is less volatile compared to SSY. This indicates lower risk in terms of short-term price fluctuations for CIRC.Check SSY's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, POM has a market cap of 7.3M. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while POM trades at $1.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas POM's P/E ratio is -0.21. In terms of profitability, CIRC's ROE is +0.00%, compared to POM's ROE of +0.16%. Regarding short-term risk, CIRC is less volatile compared to POM. This indicates lower risk in terms of short-term price fluctuations for CIRC.Check POM's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, PAVS has a market cap of 6.4M. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while PAVS trades at $7.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas PAVS's P/E ratio is -0.08. In terms of profitability, CIRC's ROE is +0.00%, compared to PAVS's ROE of -0.27%. Regarding short-term risk, CIRC is less volatile compared to PAVS. This indicates lower risk in terms of short-term price fluctuations for CIRC.Check PAVS's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, HKPD has a market cap of 4.6M. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while HKPD trades at $0.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas HKPD's P/E ratio is -6.99. In terms of profitability, CIRC's ROE is +0.00%, compared to HKPD's ROE of -0.14%. Regarding short-term risk, CIRC is less volatile compared to HKPD. This indicates lower risk in terms of short-term price fluctuations for CIRC.Check HKPD's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, AIXC has a market cap of 4.1M. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while AIXC trades at $0.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas AIXC's P/E ratio is -0.09. In terms of profitability, CIRC's ROE is +0.00%, compared to AIXC's ROE of -0.94%. Regarding short-term risk, CIRC is less volatile compared to AIXC. This indicates lower risk in terms of short-term price fluctuations for CIRC.Check AIXC's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while MDVL trades at $1.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas MDVL's P/E ratio is -0.05. In terms of profitability, CIRC's ROE is +0.00%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, CIRC is less volatile compared to MDVL. This indicates lower risk in terms of short-term price fluctuations for CIRC.Check MDVL's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while ATNFW trades at $0.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas ATNFW's P/E ratio is N/A. In terms of profitability, CIRC's ROE is +0.00%, compared to ATNFW's ROE of -2.41%. Regarding short-term risk, CIRC is less volatile compared to ATNFW. This indicates lower risk in terms of short-term price fluctuations for CIRC.Check ATNFW's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, BGMSP has a market cap of 2.4M. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while BGMSP trades at $1.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas BGMSP's P/E ratio is -0.84. In terms of profitability, CIRC's ROE is +0.00%, compared to BGMSP's ROE of -0.51%. Regarding short-term risk, CIRC is more volatile compared to BGMSP. This indicates higher risk in terms of short-term price fluctuations for CIRC.Check BGMSP's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, BGMS has a market cap of 2M. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while BGMS trades at $0.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas BGMS's P/E ratio is -0.25. In terms of profitability, CIRC's ROE is +0.00%, compared to BGMS's ROE of -0.51%. Regarding short-term risk, CIRC is more volatile compared to BGMS. This indicates higher risk in terms of short-term price fluctuations for CIRC.Check BGMS's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, AZNH has a market cap of 1.6M. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while AZNH trades at $53.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas AZNH's P/E ratio is 38.35. In terms of profitability, CIRC's ROE is +0.00%, compared to AZNH's ROE of +0.00%. Regarding short-term risk, CIRC is more volatile compared to AZNH. This indicates higher risk in terms of short-term price fluctuations for CIRC.Check AZNH's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while LFLYW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas LFLYW's P/E ratio is -0.00. In terms of profitability, CIRC's ROE is +0.00%, compared to LFLYW's ROE of +0.42%. Regarding short-term risk, CIRC is more volatile compared to LFLYW. This indicates higher risk in terms of short-term price fluctuations for CIRC.Check LFLYW's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, SBFMW has a market cap of 175.2K. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while SBFMW trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas SBFMW's P/E ratio is N/A. In terms of profitability, CIRC's ROE is +0.00%, compared to SBFMW's ROE of -0.26%. Regarding short-term risk, CIRC is less volatile compared to SBFMW. This indicates lower risk in terms of short-term price fluctuations for CIRC.Check SBFMW's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, ESRX has a market cap of 0. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while ESRX trades at $92.33.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas ESRX's P/E ratio is 10.69. In terms of profitability, CIRC's ROE is +0.00%, compared to ESRX's ROE of +0.26%. Regarding short-term risk, CIRC is more volatile compared to ESRX. This indicates higher risk in terms of short-term price fluctuations for CIRC.Check ESRX's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, POZN has a market cap of 0. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while POZN trades at $5.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas POZN's P/E ratio is N/A. In terms of profitability, CIRC's ROE is +0.00%, compared to POZN's ROE of +0.61%. Regarding short-term risk, CIRC is less volatile compared to POZN. This indicates lower risk in terms of short-term price fluctuations for CIRC.Check POZN's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, OREX has a market cap of 0. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while OREX trades at $0.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas OREX's P/E ratio is -0.14. In terms of profitability, CIRC's ROE is +0.00%, compared to OREX's ROE of -0.54%. Regarding short-term risk, CIRC is less volatile compared to OREX. This indicates lower risk in terms of short-term price fluctuations for CIRC.Check OREX's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, IPXL has a market cap of 0. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while IPXL trades at $18.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas IPXL's P/E ratio is -10.11. In terms of profitability, CIRC's ROE is +0.00%, compared to IPXL's ROE of -1.16%. Regarding short-term risk, CIRC is more volatile compared to IPXL. This indicates higher risk in terms of short-term price fluctuations for CIRC.Check IPXL's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, CPD has a market cap of 0. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while CPD trades at $5.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas CPD's P/E ratio is N/A. In terms of profitability, CIRC's ROE is +0.00%, compared to CPD's ROE of N/A. Regarding short-term risk, CIRC is more volatile compared to CPD. This indicates higher risk in terms of short-term price fluctuations for CIRC.Check CPD's competition here

Circle8 Group, Inc. (NASDAQ: CIRC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CIRC stands at 63M. In comparison, SHPG has a market cap of 0. Regarding current trading prices, CIRC is priced at $0.70 on the NASDAQ, while SHPG trades at $179.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CIRC currently has a P/E ratio of -1.59, whereas SHPG's P/E ratio is 11.35. In terms of profitability, CIRC's ROE is +0.00%, compared to SHPG's ROE of +0.13%. Regarding short-term risk, CIRC is more volatile compared to SHPG. This indicates higher risk in terms of short-term price fluctuations for CIRC.Check SHPG's competition here